Immunotherapy for breast cancer in India typically costs from AUD $20,100 to AUD $33,000. Prices depend on the specific drug, dosage, and diagnostic tests like PD-L1 markers. In Australia, patients often face costs around AUD $32,300 for similar private treatments. By choosing India, Australians can save approximately 38%. This treatment typically includes drug administration, nursing care, and oncology consultations at major medical hubs like Mumbai, Bengaluru, and Gurgaon.
Bookimed Expert Insight: Choosing large network hospitals provides significant value through advanced planning tools. For instance, Manipal Goa Hospital uses IBM Watson for oncology to refine treatment protocols. Additionally, specialists like Dr. Shruti Kate at HCG Manavata Cancer Centre bring experience from Tata Memorial Hospital. This level of expertise is accessible at a fraction of Australian private healthcare rates.
| India | Thailand | Turkey | |
| Immunotherapy for breast cancer | ≈ AUD $20,100 | ≈ AUD $11,500 | from AUD $11,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for breast cancer upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for breast cancer journey.
The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.
The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.
Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads clinical research as the Chairperson of HCG Manavata Cancer Centre.
Dr Shaunak Valame focuses on the molecular basis of cancer and specialises in targeted therapies at HCG Manavata Cancer Centre.
Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.